Key Metrics
Factor Lens
Seasonal Performance
Dividends
Per-share amounts adjusted for stock splits.
Last 12 Payouts
| Period | Ex-Date | Amount / Share |
|---|---|---|
| Q2 2026 | ~2026-06-30 | $0.8600 |
| Q1 2026 | ~2026-03-31 | $0.8600 |
| Q1 2025 | ~2025-12-31 | $0.8000 |
| Q3 2025 | ~2025-09-30 | $0.8000 |
| Q2 2025 | ~2025-06-30 | $0.8000 |
| Q1 2025 | ~2025-03-31 | $0.8000 |
| Q1 2024 | ~2024-12-31 | $0.7500 |
| Q3 2024 | ~2024-09-30 | $0.7500 |
| Q2 2024 | ~2024-06-30 | $0.7500 |
| Q1 2024 | ~2024-03-31 | $0.7500 |
| Q1 2023 | ~2023-12-31 | $0.7100 |
| Q3 2023 | ~2023-09-30 | $0.7100 |
Financial Trends
Revenue & Net Income
Earnings Per Share
Margins
Cash Flow
Company Overview
Quest Diagnostics works across the healthcare ecosystem to create a healthier world by providing diagnostic insights from clinical laboratory testing results that empower people,… physicians, and organizations to take action to improve health outcomes. The company's services derive from one of the world's largest databases of de-identifiable clinical lab results. The company serves approximately one-third of the adult U.S. population annually and approximately one-half over a three-year period, with approximately half of U.S. physicians and half of U.S. hospitals as customers. Quest Diagnostics offers an industry-leading menu of routine and advanced diagnostic testing services, including molecular diagnostics, oncology, neurology, companion diagnostics, and non-invasive genetic testing. Key offerings include reference testing for hospitals, collaborative lab solutions supporting hospital lab operations, and consumer-initiated services through QuestHealth.com. The company generated net revenues of $11.0 billion in 2025 and operates approximately 2,400 patient service centers, many located in retail settings. Quest Diagnostics serves customers including physicians, hospitals, patients and consumers, health plans, employers, government agencies, pharmaceutical companies, and commercial clinical laboratories. The company is headquartered in Secaucus, New Jersey, and was incorporated in Delaware in 1990.
- Name
- Quest Diagnostics Incorporated
- Industry
- Diagnostics & Research
- CEO
- James E. Davis · Chairman, Chief Executive Officer and President
- Employees
- 175 as of 2025-12-31
- IPO Date
- 2016-04-07
- Phone
- (973) 520-2700
- Address
- 500 Plaza Drive, Secaucus, NJ 07094
- Website
- www.QuestDiagnostics.com
Key Executives
| Name | Title | FY Pay |
|---|---|---|
| Cathy Doherty | Chief Financial Officer | — |
| James E. Davis | Chairman, Chief Executive Officer and President | — |
Latest News
- 2026-04-26
- 2026-04-24
- 2026-04-24
- 2026-04-22
- 2026-04-22
- 2026-04-21
- 2026-04-21
- 2026-04-21